Mrs Heather M Strickling, CRNA | |
799 Lexington Ave, Mansfield, OH 44907-1906 | |
(419) 756-5133 | |
(419) 774-9707 |
Full Name | Mrs Heather M Strickling |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 11 Years |
Location | 799 Lexington Ave, Mansfield, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306278445 | NPI | - | NPPES |
0090310 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 14691NA (Ohio) | Primary |
367500000X | Nurse Anesthetist, Certified Registered | APRN.CRNA.14691 (Ohio) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Ohiohealth Mansfield Hospital | Mansfield, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Anesthesia Associates Of Mansfield, Inc | 3870486624 | 24 |
News Archive
An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs), according to an article in the November 19 issue of JAMA, the Journal of the American Medical Association.
Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
Blue Spoon Consulting Group, LLC, today published a white paper that frames a new innovation space for strategy in the pharmaceutical industry. As momentum grows for performance-based contracting, connected health, and collaborative business models, drug companies will need to rethink their value proposition in a broader context.
› Verified 2 days ago
Entity Name | Ohiohealth Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs), according to an article in the November 19 issue of JAMA, the Journal of the American Medical Association.
Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
Blue Spoon Consulting Group, LLC, today published a white paper that frames a new innovation space for strategy in the pharmaceutical industry. As momentum grows for performance-based contracting, connected health, and collaborative business models, drug companies will need to rethink their value proposition in a broader context.
› Verified 2 days ago
Entity Name | Anesthesia Associates Of Mansfield, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407947815 PECOS PAC ID: 3870486624 Enrollment ID: O20040205000222 |
News Archive
An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs), according to an article in the November 19 issue of JAMA, the Journal of the American Medical Association.
Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
Blue Spoon Consulting Group, LLC, today published a white paper that frames a new innovation space for strategy in the pharmaceutical industry. As momentum grows for performance-based contracting, connected health, and collaborative business models, drug companies will need to rethink their value proposition in a broader context.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Heather M Strickling, CRNA 799 Lexington Ave, Mansfield, OH 44907-1906 Ph: (419) 756-5133 | Mrs Heather M Strickling, CRNA 799 Lexington Ave, Mansfield, OH 44907-1906 Ph: (419) 756-5133 |
News Archive
An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs), according to an article in the November 19 issue of JAMA, the Journal of the American Medical Association.
Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.
Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston.
Blue Spoon Consulting Group, LLC, today published a white paper that frames a new innovation space for strategy in the pharmaceutical industry. As momentum grows for performance-based contracting, connected health, and collaborative business models, drug companies will need to rethink their value proposition in a broader context.
› Verified 2 days ago
Ms. Esther Kay Baumann, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-774-9707 | |
Mrs. Amy Joann Secor, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-774-9707 | |
Ms. Bethany A Biddle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 | |
Michael T Platner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-526-8768 Fax: 419-522-4697 | |
Garrett Luke Bennett, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-744-9707 | |
Mrs. Kimberly Frederick, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 799 Lexington Ave, Mansfield, OH 44907 Phone: 419-756-5133 Fax: 419-774-9707 |